key: cord-0685756-ls8ik1qm authors: Ros‐Castelló, Victoria; Quereda, Carmen; López‐Sendón, José; Corral, Iñigo title: Post‐hypoxic myoclonus after COVID‐19 infection recovery date: 2020-07-17 journal: Mov Disord Clin Pract DOI: 10.1002/mdc3.13025 sha: 7536e8b7f89384a42a976c9ccf299f2ca81c2d90 doc_id: 685756 cord_uid: ls8ik1qm nan she had tachypnea and her basal oxygen saturation was 87%. A chest X-ray revealed bilateral diffuse patchy interstitial infiltrates. Nasopharyngeal swab test for SARS-CoV-2 by qualitative rRT-PCR assay was positive. Despite high flow oxygen therapy and prone position, her oxygen saturation remained 87-89%. Two days after admission she was intubated due to hypoxemia without cardiorespiratory arrest. She received standard doses of lopinavir/ritonavir, hydroxychloroquine, ceftriaxone, azithromycin, corticosteroids, meropenem and prophylactic doses of low-molecular-weight heparin. After respiratory improvement the patient was discharged from the Intensive Care Unit. A month after admission she presented progressively disabling myoclonus in upper limbs and negative myoclonus in lower limbs leading to falls (Video 1). Dysarthria, dysphagia, cognitive deficits or ataxia were not observed. In patients with COVID-19 myoclonus may be caused by metabolic disturbances (liver failure, renal failure or hypercapnia), medications (cephalosporines, quinolones or imipenem) or hypoxia. In this patient laboratory tests (including renal function, liver function, ammonium, urea and CO2) were normal at the moment of evaluation. Antibiotics, antivirals and corticosteroids had been withdrawn two weeks before the onset of the myoclonus. MRI showed cortical and brainstem ischemic lesions ( Figure 1 ). After two days of treatment with low doses of clonazepam, the myoclonus almost disappeared. Lumbar puncture, EEG and EMG were not performed due to logistic limitations related to the pandemic and the patient's clinical improvement. Taking into account all the findings, myoclonus was attributed to CNS hypoxia. This article is protected by copyright. All rights reserved. Chronic post-hypoxic myoclonus may appear days or weeks after respiratory or cardiac arrest 1 . Characteristically, it is exacerbated by muscle activation (action myoclonus) or intention (intention myoclonus) 1 . Negative myoclonus may be present in lower limbs and myoclonus may be triggered by sensory stimuli such as touch or sound 1 . Neuronal loss has been described in the thalamus, striatum, mammillary bodies or the brainstem raphe nuclei but it is not known which injured neurons generate the myoclonus 1 . Characteristic neuroimaging findings have not been defined 1 . Neurophysiological studies may help distinguish myoclonus from other movement disorders 2 . Clonazepam, valproic acid and levetiracetam have shown to be effective 1 . In some refractory cases deep brain stimulation has been used with different results 1 . COVID-19 pandemic is caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus) which has a high infectivity 4 . The virus binds to ACE2 (angiotensinconverting enzyme 2) receptors that are expressed in the lung but also in the nervous system and skeletal muscles 3 . COVID-19 infection can progress to acute respiratory distress syndrome (ARDS) in adults and 5% of infected patients may need intensive care 4 . Involvement of the brainstem region described in previous reports may suggest that the cardiorespiratory center contributes to the severe respiratory distress, although these suggestions need further investigation 4 . In addition, severe COVID-19 infection is associated with a robust systemic inflammatory response and may be accompanied by vascular endothelium dysfunction which may lead to neuroinflammation 5 . We This article is protected by copyright. All rights reserved. hypothesize that these factors may decrease the hypoxia threshold required for the development of post-hypoxic myoclonus since the patient did not suffer prolonged or severe hypoxia normally involved in Lance-Adams syndrome. SARS-CoV-2 may cause some neurologic manifestations through direct or indirect Ethical Compliance Statement: We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. The authors confirm that the approval of an institutional review board was not required for this work. Oral and written informed consent was obtained from the patient. Post-hypoxic Myoclonus: Current Concepts, Neurophysiology, and Treatment. Tremor Other Hyperkinet Mov Myoclonus: an electrophysiological diagnosis Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Parkinson's Disease and Movement Disorders